Introduction
The incidence of atherosclerosis (AS) cannot be fully explained by classical risk factors (Katz et al. 2001) . Conse-quently, the significance of infections as a potential cause of atherosclerosis has gained favour (Ridker 2002 , Epstein et al. 2009 ), which is sustained by an abundance of epidemiological evidence supporting this notion (Ross 1999 , Libby et al. 2002 . Infectious agents, including periodontal bacteria, have been implicated in the aetiology of various vascular conditions via multiple mechanisms, including direct microbial invasion of endothelial cells. This review will focus on the evidence and significance of cardiovascular host cell invasion by periodontal pathogens in the pathogenesis of atherosclerosis, as well as the different lines of evidence supporting the role of periodontal bacteria in cardiovascular diseases.
Overview of cardiovascular disease pathology
Endothelial cells play a predominant role in maintaining optimal cardiovascular function through the production of paracrine factors that modulate vasodilation, inflammation, thrombosis and cellular proliferation in the blood vessel (Vita & Loscalzo 2002) . Disruption of endothelial function is one of the earliest indicators of cardiovascular disease, which can be initiated by a number of factors (Vita & Loscalzo 2002 , Pober et al. 2009 , Kolattukudy & Niu 2012 , including infection (Vita & Loscalzo 2002 , Pirro et al. 2008 ). Chronic periodontal infections may indirectly induce endothelial activation or dysfunction through a state of systemic inflammation as evidenced by elevated plasma acutephase proteins, Interleukin-6 (IL-6) and fibrinogen (Leivadaros et al. 2005 , Buhlin et al. 2009 , Higashi et al. 2009 , Fedele et al. 2011 . Similarly, release of bacterial products into the circulation such as outer membrane vesicles (Bartruff et al. 2005) or gingipains (Fitzpatrick et al. 2009 ) from Porphyromonas gingivalis, or free soluble bacterial components from Aggregatibacter actinomycetemcomitans (Oscarsson et al. 2008) can induce pro-atherogenic responses in endothelial cells. More significantly, oral bacteria can also induce endothelial dysfunction through invasion of these cells (Table 1a -c).
Following injury, endothelial cells initiate a series of pro-inflammatory signals such as the release of chemokines, increased expression of cell adhesion molecules that promote attachment and transmigration of leucocytes into the vascular intima (Braunersreuther et al. 2007 , Woollard & Geissmann 2010 , activation of smooth muscle cells and endothelial cell death programs (Pober et al. 2009 ). Damaged endothelia also trigger platelet aggregation and initiate thrombus formation at the site of injury, which can result in vessel occlusion (Popovic et al. 2012) . Activated leucocytes that have migrated into the subendothelial space continue the inflammatory cycle through production of additional pro-inflammatory cytokines, reactive oxygen species (ROS) and the release of tissue proteinases that degrade the surrounding extracellular matrix. Although monocytes represent a predominant leucocyte within vascular plaques, lymphocytes, neutrophils, mast cells and dendritic cells have also been detected within vascular lesions (Woollard & Geissmann 2010) . Smooth muscle cells present within the intima and media layer of the vessel also contribute to vascular pathology by secreting matrix metalloproteinases (Prochnau et al. 2011 ) and undergoing proliferation (Popovic et al. 2012) . Significantly, periodontal bacteria can affect all of these processes either by directly interacting with/invading endothelial cells, smooth muscle cells, leucocytes and platelets, or indirectly by stimulating the release of paracrine factors that modulate the function of these cells.
Bacterial invasion of host cells
Host cell invasion by pathogenic bacteria represents a sophisticated strategy to counter the defences of the human body. Tissue or cellular invasion is a key virulence property for many bacterial species. It provides a "privileged niche" with access to host protein, iron and other nutritional substrates, a shelter from certain immune responses, and a mechanism for persistence in the infected tissue. An intracellular lifestyle also provides the bacterium an opportunity to avoid killing by antimicrobial therapy, as observed with Chlamydophila pneumoniae infection (Deniset & Pierce 2010) . Certain bacteria have evolved to invade nonprofessional phagocytic cells. Successful bacterial invasion, defined as survival within the host cell, can be considered to occur in five stages: (1) attachment, (2) entry/internalization, (3) trafficking, (4) persistence and (5) exit. Internalization of a bacterium also results in responses from the cell. Thus, during trafficking, a successful bacterium locates itself, sometimes by modifying cellular compartments or vesicles, and usurps host cell functions to counteract the cell antimicrobial response. Internalized bacteria can remain in a dormant state and/or multiply, resulting in persistent infection. Finally, intracellular bacteria exit either by host cell lysis (Molmeret et al. 2002) , or egress via control of a host cell process (Hertzen et al. 2010) , or by both (Hybiske & Stephens 2007) .
The concept that oral bacteria can invade host cells was controversial when Meyer et al. (1991) provided evidence that A. actinomycetemcomitans invaded KB carcinoma cells (Meyer et al. 1991) . Since this first report, several studies reporting various aspects of cell invasion by periodontal bacteria have been published (Table 1a -d, 2).
P. gingivalis as a model atherosclerosis organism
Although P. gingivalis is not the only periodontopathogenic bacterium implicated in cardiovascular disease, its interactions with cells of the cardiovascular system have been extensively studied and thus provides a model for interactions between a periodontopathogenic species and cardiovascular cells. Invasion of the host cell begins with adherence mediated by a variety of cell-surface adhesins. Since attachment to the target cell must precede entry, P. gingivalis adhesion has been extensively studied (Chavakis et al. 2005 , Nobbs et al. 2009 , Amano 2010 , Tribble & Lamont 2010 . Its attachment to and invasion of host cells is mediated by multiple adhesins such as the major fimbriae (FimA) for endothelial cells (Deshpande et al. 1998 ) and macrophages . In macrophages, FimA-mediated internalization of P. gingivalis involves crosstalk signalling from Toll-like receptor 2 (TLR2) to the b2integrin receptor complex . Some fimA genotypic clones such as type II are found most frequently in vascular tissues followed by types I and IV (Nakano et al. (2008) . In addition to fimbriae, other P. gingivalis adhesins include gingipains (Amano 2010 ) and hemagglutinins (Song et al. 2005 , Belanger et al. 2012 . Kozarov et al. (1998) reported an association between an increased number of repeat domains in hemagglutinin A (HagA) and the invasive potential of P. gingivalis. Invasive strains of P. gingivalis such as 381, 33277 and W83 contain three or more HagA repeats whereas the non-invasive strain AJW4 has only two repeats. In addition to adhesins, other bacteria in the oral microbiome may be significant since, Fusobacterium nucleatum facilitates invasion of endothelial cells by P. gingivalis (Saito et al. 2008) .
Host cell type, bacterial strain and microbial load directly influence P. gingivalis trafficking. P. gingivalis invasion of endothelial cells is an active process initiated by the bacterium that requires actin polymerization and a metabolically active cell (Deshpande et al. 1998) . P. gingivalis internalizes via lipid rafts in human aortic endothelial cells (Yamatake et al. 2007 ) and traffics via the autophagic pathway in cardiovascular endothelial and smooth muscle cells (Dorn et al. 2001) ; in contrast it utilizes the endocytic pathway during invasion of oral epithelial cells ) (see Fig. 1 ). However, only certain strains of P. gingivalis, such as 381 and W83, usurp the autophagic pathway during invasion of endothelial cells (Dorn et al. 2001) . Invasion via the autophagic pathway is observed at a low multiplicity of infection (100 MOI), which is more consistent with bacterial numbers likely to meet endothelial cells because of bacteremic events. At a higher MOI of 1000, the majority of P. gingivalis organisms travel through endosomes instead of autophagosomes (Yamatake et al. 2007 ) which suggests that bacterial dose plays a role in trafficking of P. gingivalis. In epithelial cells, P. gingivalis exits through the endocytic recycling pathway . It remains unknown if P. gingivalis exit from cardiovascular cells (Li et al. 2008 ) is through the same pathway. Regardless of the pathways employed by P. gingivalis, these strategies are likely to be critical for microbial dissemination and evasion of host cell clearance mechanisms and pathological changes within the cardiovascular system. HeLa, cervical cancer cells; HEp-2, human larynx epithelial cells, originally derived from an epidermoid carcinoma from the larynx, now known to contain contaminant HeLa cells; HGEC, human gingival epithelial cells; HN4, oral epithelial cells; HOK-16B, human gingival keratinocyte cell line; HUVEC, monolayers of human vascular endothelial cells; KB, originally thought to be derived from an epidermal carcinoma of the mouth, have now been shown to be derived from HeLa cell cultures as a contaminant; KB-R2A, a cell line defective for endosomal acidification; NIH 3T3, mouse fibroblast cells; PF HR-9, induced differentiation of an embryonal carcinoma; PHGF, primary human gingival fibroblasts; RPMI-4788, human intestinal epithelial cells; SMC, smooth muscle cells; SM9-1, mouse trophoblast cell line, derived from a gestational day 9 Swiss-Webster mouse placenta; TERT-2; oral keratinocyte cells. As stated earlier, infection with invasive P. gingivalis induces monocyte migration and significantly enhances production of the proinflammatory cytokines (Pollreisz et al. 2010) . P. gingivalis also induces pro-coagulant effects in human aortic endothelial cells (Roth et al. 2006 ) and causes apoptosis of and increases mononuclear cell adhesion to endothelial cells (Roth et al. 2007a,b) . P. gingivalis transmission occurs in vitro between primary vascular cell types, suggesting that P. gingivalis can traverse from one cell to another in vivo, such as from endothelial cells to smooth muscle cells as the atherosclerotic process progresses (Li et al. 2008) . Critical to infectious transmission, P. gingivalis survival within human vascular cell types (Li et al. 2008) , as well as uncultivable P. gingivalis could reactivate after their internalization by phagocytes .
Other periodontal pathogens in atherosclerosis
Although invasion of the endothelium and other vascular cells by P. gingivalis can certainly account for much of the atherosclerotic pathology, there is data indicating that atherosclerosis is a multi-species infection. Evidence for the detection of multiple periodontal species in individual atheromas began with the first reports of the detection of oral bacterial genomes within atheromas (Table 3 ) (Haraszthy et al. 2000a,b) . The fact that multiple oral bacterial species are associated with atherosclerosis is neither unreasonable nor unexpected, given the species complexity in dental plaque. The adherence/invasion properties of these and other periodontal pathogens follow (see Table 1b -d for in vitro studies and Table 2 for in vivo studies).
A. actinomycetemcomitans
A. actinomycetemcomitans invasion efficiency of epithelial cells is dependent on bacterial strain or microbial colony morphology, and microbial entry into host cells can occur through several receptors (Meyer et al. 1991 , 1996 , Meyer & Fives-Taylor 1997 . For example, A. actinomycetemcomitans may be gaining entry into host cells through engagement with transferrin and integrin receptors (Meyer & Fives-Taylor 1997) . Moreover, A. actinomycetemcomitans entry into host cells is strain variable in that some strains enter host cells through an actin-dependent mechanism, while other strains employ an actin-independent entry into host cells . During the past decade, several research groups have added to our knowledge of A. actinomycetemcomitans invasion (see Table 1b ). Among these, it was demonstrated that A. actinomycetemcomitans invasion of human vascular endothelial cells involves an interaction between bacterial phosphorylcholine (PC) and the platelet-activating factor (PAF) receptor of the host cell (Schenkein et al. 2000) . lial and smooth muscle cells) in vitro (Table 1c ). The type C. fimbriae and the invasin protein, AdpC (belonging to the leucine-rich repeat protein family) appear to mediate the invasion process.
Tannerella forsythia
Multiple T. forsythia strains attach to and invade epithelial cells in vitro, mediated by the surface layer composed of proteinaceous arrays (Sabet et al. 2003 , Sakakibara et al. 2007 ) (Table 1c ). Similar to P. intermedia, epithelial cell attachment and invasion are also dependent on a cell-surface associated leucine-rich repeat protein, BspA. Interestingly, P. gingivalis or its outer membrane vesicles enhance T. forsythia attachment and invasion (Inagaki et al. 2006) . At present, there is minimal information about T. forsythia interactions with cardiovascular cells.
F. nucleatum
Many strains of F. nucleatum are invasive in vitro (Table 1d ). The F. nucleatum adhesin, FadA, appears to be required for both attachment and invasion (Ikegami et al. 2009 ). F. nucleatum may also transport noninvasive species (e.g. streptococci) into host cells via a combination of co-aggregation and invasion mechanisms and also facilitate P. gingivalis invasion of human gingival epithelial and endothelial cells (Saito et al. 2008 ), but evidence of F. nucleatum co-aggregation among different combinations of species including P. gingivalis, T. denticola or T. forsythia is equivocal (Kirschbaum et al. 2010 ).
Other oral bacterial species
There is limited in vitro ( Emerging mechanisms of atherosclerosis: autophagy as an endothelial stress response and its perturbation by P. gingivalis Autophagy represents a reparative cellular response that degrades senescent cellular organelles, damaged intracellular proteins, and invading intracellular bacteria (Dorn et al. 2002a , Deretic 2011 .
There is emerging evidence that the autophagic response may influence cardiovascular disease outcomes during atherosclerosis by affecting plaque stability (Martinet & De Meyer 2008 , Schrijvers et al. 2011 ). For instance, increased autophagic activity measured by LC3 activation or expression have been detected within atheromatous plaques from humans and murine models of sterile atherosclerosis (Martinet & De Meyer 2008 , Liao et al. 2012 ). Further, ApoE-null mice fed high fat diets exhibit impaired autophagy within the atheromatous plaque as disease progresses (Liao et al. 2012) , and impaired autophagy has been linked to increased inflammation, which has pro-atherogenic effects (Razani et al. 2012) .
In sterile atherosclerosis, autophagy is considered a protective mechanism that prevents apoptosis in cells that are undergoing oxidative stress (Scherz-Shouval & Elazar 2007 , Xie et al. 2011 or endoplasmic reticulum stress (Bernales et al. 2006 , Zhang et al. 2010a , which is a common feature of atherosclerotic disease. However, in vitro studies have demonstrated that over-activation of autophagy or dysregulation of the autophagic pathway in cardiovascular cells can also be detrimental (Larocca et al. 2012 ) by promoting cell death referred to as "necroptosis" (Khan et al. 2012 , Kolattukudy & Niu 2012 , which is potentially pro-atherogenic due to its proinflammatory effect (Kolattukudy & Niu 2012) .
As an innate immune clearance mechanism, autophagy can be activated in response to signalling via toll-like receptors (TLRs), Nod-like receptors (NLRs) and/or the sequestasome , Anand et al. 2011 , Deretic 2011 . Some intracellular pathogens including P. gingivalis have developed strategies to subvert this line of defence (Deretic & Levine 2009). P. gingivalis strain 381 usurps the autophagic pathway during invasion of human coronary artery endothelial cells and smooth muscle cells in vitro, as shown in Fig. 1 (Dorn et al. 2001) . Specifically, bacteria delay fusion of the autophagosome with lysosomes thus, interfering with autophagic flux. This process may impair the ability of the host cell to use the autophagic response as a means of rescuing the cell from oxidative or endoplasmic reticulum stress. Rodrigues et al. (2012) have recently demonstrated that not all P. gingivalis strains manipulate this pathway during host cell invasion; W83 perturbs the autophagic pathway of endothelial cells in a similar fashion as 381, whereas strains A7436 and 33,277 do not.
Evaluation of the evidence
In a clinical setting, it is extremely difficult to establish the causative factor of atherosclerosis for several reasons. First, the initiating factor is likely to be missed since the early phase of endothelial injury is usually asymptomatic (Vita & Loscalzo 2002) . Second, the atherosclerotic lesion is a common inflammatory response to multiple factors (Keizer 2012 , Raman et al. 2013 , and some or all of those factors may be associated with the lesion at the time of discovery. Third, interventional studies that evaluated the impact of periodontal treatment, with or without antimicrobial therapy, on systemic inflammation or endothelial dysfunction, have shown mixed results In vitro evidence of invasion of affected cell types. 5
Demonstration that periodontal bacteria can promote atherosclerosis in animal models of disease. 6
In vitro and in vivo evidence that non-invasive mutants cause significantly reduced pathology (animal model). 7
Fulfil modified Koch's postulate to demonstrate that a human atheroma isolate causes disease in animal models.
including no change, transient worsening of signs immediately after treatment, or improvement in signs that did not necessarily persist over time (extensively reviewed by Kebschull et al. 2010) . Despite these limitations, it is possible to, at least, demonstrate biological plausibility that invasion of cardiovascular tissues by periodontal bacteria have the potential to promote atherosclerosis through fulfilment of several proofs, discussed elsewhere in the article ( Table 3) .
Proof that periodontal bacteria can reach systemic vascular tissues
There is no doubt that oral bacterial species can enter the circulation and cause bacteremia ( • As the gingival pocket is separated from gingival micro-capillaries by a few cells, it is thought that periodontal species that invade oral cells can cross this layer and enter the circulation via a transcellular mechanism ).
• More often, however, periodontal bacteria likely enter the circulation following physical perturbations of the gingiva. Among these perturbations, some are related to dental procedures such as tooth polishing, scaling, tooth extraction, surgical extraction of third molar and periodontal probing (see Table 4a -d). Other perturbations are daily life activities, including tooth brushing, flossing, chewing or biting an apple, as listed in Table 4a -d. The frequency of bacteremia showed a wide variability, depending on the study design, the microbiological methodology, the stimulus and the periodontal health status of the patients. In some studies, an association with plaque and/or gingival indices has been reported (Silver et al. 1977 , Forner et al. 2006 , Lockhart et al. 2009 ). A recent systematic review with meta-analysis on the prevalence of bacteremia following tooth brushing, evaluated the pooled odds ratios of the influence of plaque and gingival indices at 2.61 and 2.77 respectively (Tomas et al. 2012 ). In addition, as shown in Table 4a -d, multiple studies have detected different bacteremic periodontal pathogens, especially after subgingival debridement procedures in periodontitis patients. However, these results should be interpreted with caution due to variability among these studies, which may be due to limitations of the methodology that was used that may affect the sensitivity and detection thresholds (culture-based methods). In addition, well-validated PCR-based methods were not frequently used.
• Another proposed but unproven mechanism of bacteremia is that periodontal bacteria enter the circulation and disseminate to distant sites via survival in immune cells (the Trojan horse approach) (Carrion et al. 2012 ). In such cases, phagocytosis is beneficial to the bacterial pathogen but detrimental to the host. In this scenario, the internalized pathogen evades microbial killing within the leucocyte and is able to escape from the phagocyte after the cell reaches another site within the body (Zeituni et al. 2009 ). For example, P. gingivalis gains entry into dendritic cells and disrupts their phagocytic function as evidenced by retention of an immature phenotype characterized by a low production of inflammatory mediators (Zeituni et al. 2009 (Zeituni et al. , 2010 . Regardless of mechanism, there is no doubt that oral pathogens frequently enter the circulation.
Proof that periodontal bacteria can be found in the affected tissues
Since bacteremias of oral origin are frequent, the association of periodontal pathogens with atherosclerotic pathology has been the focus of multiple studies. A variety of oral bacterial species have been identified in atheromatous tissues at the DNA, RNA or antigen level. Haraszthy et al. (2000a) were the first to report the detection of the genomic DNA of A. actinomycetemcomitans, P. gingivalis and other species using bacterial 16S rRNAspecific PCR analysis. These PCR detection stud-ies were further extended and confirmed by others (Tables 5, 6) . Interestingly, most of these reports found evidence of multiple species in individual atheromas. Thus, there is sufficient data to conclude that multiple pathogenic species reach the affected site. However, the impact of these results are somewhat hampered by several factors. For example, the presence of bacterial components (DNA, RNA and antigens) does not distinguish between live and dead bacteria within the tissue. Further, some species of bacteria,, such as Veillonella sp, which have been detected within atheromas (Koren et al. 2011) , are not cultivable (Chalmers et al. 2008 ). Finally, not all studies have detected microbial products within the atheroma, and this lack of consistency may be due to differences in methodology (Figuero et al. 2011) or underlying aetiology of the atheroma.
Evidence of live periodontal bacteria at the affected site
For several years, multiple groups attempted to culture periodontopathogenic organisms from atheromas to no avail. Finally, Kozarov et al. (2005) reported evidence of live P. gingivalis and A. actinomycetemcomitans in atheromatous tissue. This was accomplished by incubating homogenized atheromatous tissue in culture with primary human coronary artery endothelial cells (HCAECs). After several days of incubation, the group used fluorescently labelled antibodies and deconvolution microscopy to visualize intact bacteria within the endothelial cells. Because both species must be alive in order to invade, the presence of the bacteria within the non-phagocytic cells provided strong evidence of the existence of live bacteria in the atheromas. In addition, Rafferty et al. (2011) cultured atheroma samples with macrophages as an intermediate step and was able to isolate P. gingivalis on culture plates. These studies require fresh atheromas (angioplasty and stenting have become the standard of care) and the complexity of the protocol appears to have precluded confirmatory reports to date. Thus, although periodontal pathogens cannot routinely be cultured from atheromas directly onto plates, there is evidence that live periodontal bacteria are present in at least some atheromas.
In vitro evidence of invasion of affected cell types
There are indisputable data that, at least, some periodontal pathogens invade human cardiovascular cells in vitro (Table 1a-d) . Deshpande et al. (1998) and Dorn et al. (1999) were the first to report invasion of endothelial cells by P. gingivalis. Since these first reports, there have been a number of research groups who have provided details of the mechanisms of cardiovascular cell invasion by P. gingivalis (Dorn et al. 2000 , 2002b , Rodrigues & Progulske-Fox 2005 , Takahashi et al. 2006 , Li et al. 2008 . These have been discussed previously.
Demonstration that periodontal bacteria can promote atherosclerosis in animal models of disease Animal models can be used to support in vitro data-based hypotheses (Graves et al. 2008) and have been used to demonstrate atherosclerotic pathology caused by periodontal pathogens. For example, P. gingivalis has been reported by multiple groups to accelerate atherosclerosis in murine models (Lalla et al. 2003 , Gibson et al. 2004 , Amar et al. 2009 ). In addi-tion to murine models, rabbits with experimentally induced periodontal disease developed fatty streaks in the aorta faster than in periodontally healthy animals (Jain et al. 2003) . In normocholesterolemic pigs, recurrent P. gingivalis bacteremia induced both aortic and coronary lesions, and P. gingivalis bacteremia also enhanced atherosclerosis in hypercholesterolemic pigs (Brodala et al. 2005) . Thus, in addition to the identification of live periodontal organisms in human atherosclerotic plaque, in vivo experiments in a variety of animal models have provided biological plausibility that P. gingivalis can enhance atherogenesis. Mutants with significantly reduced ability to invade in vitro have also been evaluated in vivo. In contrast to the invasive wild-type strain of P. gingivalis, the non-invasive fimA deficient mutant did not accelerate atherosclerosis in ApoE knockout mice Gibson et al. (2004) . Moreover, the fimA deficient mutant was less pro-atherogenic and elicited a lower level of pro-inflammatory mediators than the invasive parental strain in ApoE deficient mice. However, there is minimal data using other periodontal species in animal models.
Fulfill modified Koch's postulate to demonstrate that a human atheroma isolate causes disease in animal models
The final proof, fulfilling a variation of Koch's postulates, has not yet been achieved. It requires the isolation and characterization of periodontopathogens from human atheromas and the demonstration that the isolates cause atherosclerotic pathology in animal models attributable to the bacterial isolates(s). Given the success by at least one group in culturing strains of P. gingivalis from human atheromas , this could be accomplished in the future. An analogous approach has been used to investigate the role of an invasive strain of Streptococcus mutans in infectious brain aneurisms, with demonstration that a mutant deleted for the gene that allows invasion was not able to cause disease (Nakano et al. 2011 ).
Discussion
In this review, the evidence to assess the direct role of periodontopathogens in atherosclerosis has been evaluated considering seven proofs:
• Proof 1should be considered validated since the literature is convincing that oral microorganisms obtain access to the circulation.
• Proof 2periodontal bacteria have been identified in human atheromas by several groups using multiple detection technologies. Thus, there is little question that oral bacteria are found in human atheromas. However, visual proof of bacteria inside cells in the atheromas is still lacking. If only a minority of cells contain bacteria, transmission electron microscopy (TEM) may be too inefficient to find them. Also, there is some variation in the organisms identified in the tissues. This could be attributed to differences in techniques used or the inter-individual diversity of oral organisms able to infect atheromas. Eventually, this hypothesis could be tested in animal models but the complexity of the microbiome will complicate the models.
• Proof 3data using indirect means of culture that support proof 3, have been published but additional comfirmative studies are needed. In vitro, P. gingivalis becomes dormant or viable, but not culturable (Li et al. 2008) , and in vivo viable bacteria have been cultured from atheroma homogenates following in vitro cultivation in cell lines . It is possible that the same phenomenon occurs in vivo and that contact with "fresh" uninfected cells provides the signals to the bacteria to emerge from dormancy.
• Proof 4in vitro evidence of invasion of affected cell types is indisputable. During the past 15 years, there have been a series of papers reporting the invasion of cardiovascular cell types by periodontal bacteria.
• Proof 5it is also well documented using various animal models since the periodontal bacteria tested in these models caused increased frequency and size of atherosclerotic lesions. To the extent that animal models of atherosclerosis represent human disease, then this proof is satisfied. One goal should be the inclusion of more complex mixtures of bacteria in these models.
• Proof 6the invasion and disease phenotype, that is, significantly reduced disease caused by non-invasive mutants compared to the wild-type parental strain is also documented by multiple research groups. Although experiments with additional invasive mutants will prove interesting and informative, the present data confirm this proof for specific strains.
• The final proof, Proof 7, is yet to be accomplished. As atheromatous specimens become more and more difficult to obtain, we may be close to missing the window of opportunity to test this final proof.
Proposal of a model
We present a model (Fig. 2) 
Significance of strain
Throughout the microbial world, there are strain differences within a species and these differences sometimes influence virulence. We propose that such is the case for periodontopathogenic species in relation to cardiovascular diseases. There are multiple examples cited in this review that illustrate phenotypic differences among strains of a (1999) reported the invasive heterogeneity of A. actinomycetemecomitans strains. Also, as discussed above, only certain P. gingivalis strains induce autophagy in endothelial cells and strains vary in the number of repeats in the HagA adhesin. In addition, we have tested over 20 P. gingivalis strains for the ability to invade various cell types (Dorn et al. 2000) . Our results revealed a wide ability among strains to invade cardiovascular cells with strains grouped into categories including high invaders, moderate invaders and non-invaders. Thus, it is likely that different strains of P. gingivalis induce varying responses in promoting endothelial dysfunction. For example, P. gingivalis 381 (fimbriae type I) induces gene expression of GroA, GroE, IL-6, IL-8, vascular cell adhesion mole-cule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1 in HCAECs, which is a fimbriae dependent phenomenon ) that is mediated through engagement of TLRs . Conversely, P. gingivalis strain W83, which is capsule positive but does not express fimbriae, induces moderate activation of TLR2 and an attenuated inflammatory response in HCAEC when compared to 381 (Rodrigues et al. 2012) . Similarly, capsule positive A7436, which expresses type IV fimbriae, also induces a moderate inflammatory response in HCAEC (unpublished data). Interestingly, both W83 and A7436 can accelerate atherosclerosis in ApoE-null mice (Li et al. 2002 , Maekawa et al. 2011 , suggesting that periodontal bacteria can promote atherosclerosis through other mechanisms that may not involve profound activation of endothelial cells. Interestingly, similar studies with S. mutans strains have demonstrated that 10-15% of strains can invade cardiovascular endothelial cells and that an invasive strain caused significant pathology compared to control mice in an ApoE-/-mouse model of accelerated atherosclerosis (Kesavalu et al. 2012) .
Consequently, based on the available information, we suggest that only specific strains of invasive periodontopathogens play a role in infections of cardiovascular tissues. The significance of this is that individuals harbouring these strains may be at a higher risk for cardiovascular diseases (Nakano et al. 2007 ). Consequently, the chair-side detection of pro-atherogenic strains may be a goal of the future.
Conclusions
In conclusion, considering the evidence for the postulates provided here, there is strong, but not yet conclusive, evidence for invasion of human cardiovascular cells by periodontal bacterial species as one mechanism of atherosclerosis. Since Koch's Postulates cannot be applied to humans, in this case we suggest a modified Koch's postulate be tested if, and when appropriate strains and mutants of those strains are obtained and constructed. Thus, additional work is required to confirm or dispute this aetiology. This additional work would not only lead to better understanding of the mechanisms of infectious atherosclerosis but also may be a key to the design of novel and effective treatment and preventive approaches. Model representing what is now known about the microbial component of atherogenesis. Both bacteremic and phagocyte-mediated avenues of bacterial delivery to the site of inflammation are proposed. Bacteremia-related bacteria (left) are shown invading the endothelial layer and further spreading into deeper tissue. Activation of infected endothelia are represented with the release of pro-inflammatory chemokines (such as MCP-1) in the lumen, activating blood monocytes (MN) and macrophages (MΦ) and promoting their adhesion and diapedesis. Transmigrating leucocytes (in the centre) can harbour internalized viable bacteria, which represents the second avenue for systemic bacterial dissemination to distant sites. The internalization of bacteria can switch them into uncultivable state (red into green), while their internalization by phagocytes can reactivate them (from green to red). Atheromas can grow due to macrophage-secreted growth factors-mediated smooth muscle cell proliferation. Bacteria are also released upon host cell death (depicted at right). MN, monocyte. MΦ, macrophage with internalized bacteria. EC, endothelial cell. SMC, smooth muscle cell. Apoptotic EC, apoptotic endothelial cell releasing intracellular bacteria.
